Inovio Pharmaceuticals (INO) Receivables - Net (2016 - 2025)
Inovio Pharmaceuticals (INO) has disclosed Receivables - Net for 16 consecutive years, with $450.0 as the latest value for Q4 2025.
- Quarterly Receivables - Net fell 99.96% to $450.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $450.0 through Dec 2025, down 99.96% year-over-year, with the annual reading at $450.0 for FY2025, 99.96% down from the prior year.
- Receivables - Net hit $450.0 in Q4 2025 for Inovio Pharmaceuticals, down from $978590.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $9.9 million in Q1 2021 to a low of $450.0 in Q4 2025.
- Historically, Receivables - Net has averaged $2.7 million across 5 years, with a median of $2.1 million in 2023.
- Biggest five-year swings in Receivables - Net: skyrocketed 3380.14% in 2024 and later crashed 99.96% in 2025.
- Year by year, Receivables - Net stood at $5.5 million in 2021, then crashed by 68.9% to $1.7 million in 2022, then soared by 41.48% to $2.4 million in 2023, then plummeted by 50.15% to $1.2 million in 2024, then plummeted by 99.96% to $450.0 in 2025.
- Business Quant data shows Receivables - Net for INO at $450.0 in Q4 2025, $978590.0 in Q3 2025, and $840312.0 in Q2 2025.